| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.057 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |